FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology
Posted:
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its Percept™ RC Deep Brain Stimulation (DBS) system.
Healthcare is changing rapidly—and organisations that are helping shape the future of health and care need a platform to share their expertise, connect with decision-makers, and demonstrate the impact of their solutions.
GIANT Health Event 2026 offers companies the opportunity…
Healthcare innovation happens when people come together.
That’s why GIANT Health Event 2026 is offering free tickets for NHS professionals, giving healthcare leaders, clinicians, and teams the opportunity to connect, learn, and explore the latest innovations transforming the future of…
Attendees
Sponsors and Exhibitors
Contact us